Biolife Solutions (BLFS) Long-Term Deferred Tax (2012 - 2013)

Biolife Solutions (BLFS) reported Long-Term Deferred Tax of $9.6 million for Q4 2013, up 3.7% year-over-year from $9.2 million in Q4 2012, and up 3.7% quarter-over-quarter from $9.2 million in Q4 2012.

Biolife Solutions (BLFS) Long-Term Deferred Tax (2012 - 2013) Analysis & Trends

Biolife Solutions (BLFS) has 2 years of Long-Term Deferred Tax data on file, last reported at $9.6 million in Q4 2013.

  • Long-Term Deferred Tax for Q4 2013 came in at $9.6 million, up 3.7% year-over-year; the trailing twelve-month figure through Dec 2013 was $9.6 million (up 3.7% YoY), and the FY2013 annual result was $9.6 million, up 3.7% from the prior year.
  • Long-Term Deferred Tax improved to $9.6 million in Q4 2013 per BLFS's latest filing, from $9.2 million in the prior quarter.
  • Over five years, Long-Term Deferred Tax peaked at $9.6 million in Q4 2013 and troughed at $9.2 million in Q4 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn
10 Biolife Solutions 1.27 Bn 1.19 Bn 17.50 Mn

Historic Data

Download Data
DateValue
Dec 31, 2013 9.59 Mn
Dec 31, 2012 9.24 Mn